MSB 7.69% $1.19 mesoblast limited

Ann: Long-Term Survival for Acute GvHD Treatment with Remestemcel, page-242

  1. 16,651 Posts.
    lightbulb Created with Sketch. 2375
    LoL, Lopez what will you do if the aGVHD BLA resubmission (which despite your exhortations and false claims HAS NOT happened yet)... is rejected by the FDA and they say they want to see a proper trial?

    Are you a buyer at 0.5c?
    Last edited by whytee: 29/11/22
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.